21042 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4) Metalloendopeptidases (3.4.24), e.g. collagenase
Sub-classes:Method of Chemically Loosening Adhesions and Kit for Same
#2THERMOSENSITIVE HYDROGEL COLLAGENASE FORMULATIONS
#3DISSOLVABLE GEL-FORMING FILM FOR DELIVERY OF ACTIVE AGENTS
#4COMPOSITION FOR INHIBITING LIPOFUSCIN ACCUMULATION OR REMOVING LIPOFUSCIN CONTAINING METALLOPROTEASE DERIVED FROM A STRAIN OF THE GENUS CHRYSEOBACTERIUM
#5COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION
#6AMNIOTIC FLUID COMPOSITION AND METHOD OF USING
#7METHOD FOR TREATING SEPSIS AND RELATED DISEASES
#8Methods Of Treating Plantar Fibromatosis
#9Methods Of Treating Plantar Fibromatosis
#10ENHANCED MACROPHAGES
#11SYSTEMS AND METHODS FOR EPICARDIAL TISSUE DISTENSION SOLUTIONS
#12IMMUNOMODULATORY COMPOSITIONS AND METHODS
#13PHARMACEUTICAL COMPOSITION FOR TREATING WOUND REPAIR AND PREPARATION METHOD THEREOF
#14Methods Of Treating Plantar Fibromatosis
#15Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#16CO-TRANSPLANTATION OF MMP-9 ENHANCED MESENCHYMAL STEM CELLS AND PANCREATIC ISLETS FOR THE TREATMENT OF DIABETES
#17ACTIVATORS OF COAGULATION FACTOR X AND FORMULATIONS THEREOF FOR TREATING BLEEDING DISORDERS
#18Method of Using r-SAK Prior to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
#19Thrombolytic Protease Resistant ADAMTS13 Mutants
#20METHOD OF ASSESSING AND TREATING CELLULITE
#21Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#22NOVEL LIQUID FORMULATION FOR PLASMA PROTEIN
#23METHODS OF CANCER TREATMENT BY INTRATUMORAL INJECTION OF MUTANT COLLAGENASE
#24COLLAGENASE FORMULATIONS AND METHODS OF PRODUCING THE SAME
#25BLOOD BIOMARKERS IN LONG-COVID-19
#26Treatment Of Uterine Fibroids Using Purified Collagenase
#27TRUNCATED FORMS OF IGA PROTEASE, FUSION PROTEINS COMPRISING A TRUNCATED FORM OF IGA PROTEASE AND USES THEREOF
#28METHODS OF TREATING, AMELIORATING AND/OR PREVENTING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND HETEROTOPIC OSSIFICATION, AND KITS FOR THE SAME
#29CLOSTRIDIUM HISTOLYTICUM ENZYMES AND METHODS FOR THE USE THEREOF
#30ENHANCED DELIVERY OF ANTIOXIDANTS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS INVOLVING OXIDATIVE STRESS
#31METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES
#32METHODS AND COMPOSITIONS FOR INHIBITING ADAM9 BIOLOGICAL ACTIVITIES
#33NOVEL BACTERIA-BASED DELIVERY SYSTEM FOR TACE (ADAM17) SELECTIVE BIOLOGICAL INHIBITOR
#34NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY
#35COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE CELL FUNCTION USING MODIFIED CELLS WITH GLYCOCALYX EDITING ENZYMES
#36ENDOSCOPIC, PERCUTANEOUS AND OTHER METHODS FOR DISSOLUTION OF PANCREATIC NECROSIS
#37ORAL DOSAGE FORM WITH A GASTRO RESISTANT CAPSULE SHELL
#38STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS
#39CORYNEBACTERIUM TO TREAT OR LIMIT CUTANEOUS WOUND INFECTION
#40METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS
#41METHODS, APPARATUSES AND SYSTEMS FOR ADOLESCENT IDIOPATHIC SCOLIOSIS TREATMENT
#42Pharmaceutical compositions comprising collagenase I and collagenase II
#43ENDOTOXIN-REDUCED THERMOLYSIN
#44COMPOSITIONS AND METHODS FOR PRODUCING CLOSTRIDIAL COLLAGENASES
#45RECOMBINANT POLYPEPTIDE FOR USE AS A MEDICINE, ANTISEPTIC AGENT, ANTIBACTERIAL AGENT, ANTI-INFLAMMATORY AGENT, COMPOSITIONS COMPRISING IT AND USES THEREOF
#46Nanoparticles Having Molecules That Bind or Block PD-L1 and Uses In Treating Cancer
#47METHOD OF MITIGATION OF INJURIES CAUSED BY SYSTEMIC GENOTOXIC STRESS
#48LYSOSTAPHIN VARIANTS AND METHODS OF USE THEREOF
#49STABLE THERMOLYSIN HYDROGEL
#50DISSOLVABLE GEL-FORMING FILM FOR DELIVERY OF ACTIVE AGENTS
#51MODIFIED RECOMBINANT COLLAGENASE, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF IN DENTAL RELATED PROCEDURES
#52SOLUBILIZATE WITH AT LEAST ONE CANNABINOID
#53COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#54HUMANIZED ANTI-MUC1* ANTIBODIES AND DIRECT USE OF CLEAVAGE ENZYME
#55Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies
#56NUCLEIC ACID MOLECULES ENCODING CLOSTRIDIUM HISTOLYTICUM COLLAGENASE I AND METHODS OF PRODUCING THE SAME
#57USE OF CLOSTRIDIUM HISTOLYTICUM PROTEASE MIXTURE IN PROMOTING WOUND HEALING
#58Clostridium Histolyticum Enzymes And Methods For The Use Thereof
#59PEPTIDES FOR THE TREATMENT OF CANCER AND/OR METASTASIS
#60METHOD OF TREATING OR REDUCING EFP
#61Solubilizate with curcumin and optionally at least one other active substance
#62A PHARMACEUTICALLY ACCEPTABLE AQUEOUS GEL COMPOSITION FOR MRNA DELIVERY
#63Treatment Of Uterine Fibroids Using Purified Collagenase
#64DIAGNOSTIC AGENT AND MEDICINE COMPRISING ADAMTS13 AS MAIN INGREDIENT
#65FUNGAL PROTEASE MIXTURES AND USES THEREOF
#66Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#67TRUNCATED MODIFIED RECOMBINANT ADAMTS13 AND USES THEREOF
#68COMPOSITION FOR TREATING OR PREVENTING MYOPATHY, OBESITY OR DIABETES
#69Collagenase formulations and methods of producing the same
#70COMPOSITIONS FOR REMODELING EXTRACELLULAR MATRIX AND METHODS OF USE THEREOF
#71COMPOSITIONS FOR THE TREATMENT OF FAT RELATED CONDITIONS AND DISORDERS
#72METHOD OF ASSESSING AND TREATING CELLULITE
#73Nucleic acid molecules encoding clostridium histolyticum collagenase II and methods of producing the same
#74METHODS OF REDUCING COLLAGENASE-MEDIATED BRUISING IN A SUBJECT HAVING CELLULITE
#75ADAMTS13 VARIANT HAVING INCREASED ESCAPING RATE OR ACTIVITY AGAINST AUTOANTIBODY
#76Nanoparticles having molecules that bind or block PD-L1 and uses in treating cancer
#77FIBRINOLYTIC ENZYME COMPOSITION FOR FIBROSIS TREATMENT
#78USE OF THERMOLYSIN TO REDUCE OR ELIMINATE BACTERIAL BIOFILMS FROM SURFACES
#79IMMUNOSUPPRESSIVE AGENTS
#80ENHANCEMENT OF CARTILAGE REGENERATIVE ACTIVITY OF STEM CELL POPULATIONS BASED ON REDUCTION OF INTRA-ARTICULAR CELLULAR MATERIAL
#81A DISINTEGRIN AND METALLOPROTEINASE WITH A THROMBOSPONDIN TYPE I MOTIF, MEMBER 13 (ADAMTS-13) MUTANTS, COMPOSITIONS AND THERAPEUTIC METHODS THEREOF
#82PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND APPLICATION THEREOF
#83ADAMTS13 VARIANT, COMPOSITIONS, AND USES THEREOF
#84Methods and compositions for inhibiting ADAM10 biological activities
#85ADAMTS13 COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING COMPLICATIONS OF CORONAVIRUS DISEASE
#86Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
#87Methods of treating cancer using neuronal activity inhibiting agents
#88RNAS FOR WOUND HEALING
#89DIAGNOSTIC AGENT AND MEDICINE COMPRISING ADAMTS13 AS MAIN INGREDIENT
#90COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#91RNA FOR TREATMENT OR PROPHYLAXIS OF A LIVER DISEASE
#92Pulmonary Administration of ACE2 Polypeptides
#93Compositions And Methods To Reduce And/Or Dissolve Calcium Deposits In Arterial Walls
#94Stabilized liquid and lyophilized ADAMTS13 formulations
#95Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress
#96Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes
#97Dissolvable gel-forming film for delivery of active agents
#98Stable thermolysin hydrogel
#99COMPOSITIONS AND METHODS FOR REGULATING SAS1R
#100METHOD OF USING ALLOGENEIC HAPLOIDENTICAL ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION IN THE TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME PATIENT
#101CHIMERIC PROTEINS FOR SELECTIVE LYSIS OF BACTERIA
#102ENDOTOXIN-REDUCED THERMOLYSIN
#103COMPOSITIONS AND METHODS FOR WOUND HEALING
#104VIRAL MEDIATED GENE DELIVERY FOR TRANSIENT EXPRESSION OF PROTEINS
#105Compositions for remodeling extracellular matrix and methods of use thereof
#106WOUND DEBRIDEMENT SYSTEMS
#107ADAMTS13 TREATMENT TO ENHANCE GRAFT SURVIVAL
#108Collagenase Clostridium for Treating Esophageal Ailments
#109COLLAGENASE FORMULATIONS AND METHODS OF PRODUCING THE SAME
#110USE OF RECOMBINANT ADAMTS13 FOR TREATING SICKLE CELL DISEASE
#111SOLUBILIZATE WITH CURCUMIN AND BOSWELLIA AND XANTHOHUMOL
#112METHODS FOR TREATING CELLULITE
#113AN AMNIOTIC FLUID COMPOSITION AND METHOD OF USING
#114ENZYME-DEGRADABLE HYDROGEL FOR DELIVERY OF A PAYLOAD
#115SOLUBILIZATE WITH CURCUMIN AND AT LEAST THE CANNABINOID THC AS A FURTHER ACTIVE SUBSTANCE
#116SOLUBILIZATE WITH CURCUMIN AND AT LEAST ONE CANNABINOID AS A FURTHER ACTIVE SUBSTANCE
#117Solubilizate with curcumin and optionally at least one other active substance
#118IMMUNOMODULATORY COMPOSITIONS AND METHODS
#119Subcutaneous administration of ADAMTS13
#120PEPTIDE DIRECTED PROTEIN KNOCKDOWN
#121Collagenase for treatment of bladder dysfunction
#122Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
#123CHEMICAL SCALPEL
#124BLOOD COMPONENT POTENTIATION OF LYTIC PROTEIN ANTI-BACTERIAL ACTIVITY AND METHODS AND USES THEREOF
#125ADAMTS13-CONTAINING COMPOSITIONS HAVING THROMBOLYTIC ACTIVITY
#126Liquid Crystalline Collagen Materials and Use in Connective Tissue Repair
#127Deimmunized lysostaphin and methods of use
#128PREPARATION METHOD AND APPLICATION OF RECOMBINANT MUTANT COLLAGENASE
#129Method of assessing and treating cellulite
#130RESCUING CANCER PATIENTS FROM RESISTANCE TO TREATMENT WITH INHIBITORS OF PD-1/PD-L1 INTERACTIONS
#131COMBINATION THERAPY CONTAINING IMMUNE BOOSTERS, DIGESTIVE ENZYMES AND INTERFERONS FOR CANCER TREATMENT
#132PEGYLATED TETANUS NEUROTOXINS AND TREATMENT OF HYPOTONIA
#133Methods, apparatuses and systems for adolescent idiopathic scoliosis treatment
#134Collagenase Clostridium Histolyticum injection therapies
#135WOUND PREVENTION AND/OR TREATMENT AND RELATED COMPOUNDS, MATRICES, COMPOSITIONS, METHODS AND SYSTEMS
#136CONTACT LENS USE IN THE TREATMENT OF AN OPHTHALMOLOGIC CONDITION
#137METHOD OF USING ALLOGENEIC HAPLOIDENTICAL ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION IN THE TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME PATIENT
#138CELLULITE ERADICATION METHODS
#139Treatment method and product for uterine fibroids using purified collagenase
#140Suppression of bone cancer-induced allodynia
#141INJECTION TECHNIQUES FOR THE TREATMENT OF CELLULITE
#142VARIANTS OF TACE PRO-DOMAIN AS TNF-A INHIBITOR AND THEIR MEDICAL USE
#143Directed stem cell recruitment
#144COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION
#145Treatment of uterine fibroids using purified collagenase
#146COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#147COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#148Methods and compositions for treatment of penile defects
#149THERMOSENSITIVE HYDROGEL COLLAGENASE FORMULATIONS
#150Collagenase loaded liposomes for enhancing drug delivery
#151COMPOSITIONS AND METHODS FOR PRODUCING CLOSTRIDIAL COLLAGENASES
#152Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#153Compositions for remodeling extracellular matrix and methods of use thereof
#154Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases
#155COMPOSITIONS, SYSTEMS, AND METHODS FOR SCAR TISSUE MODIFICATION
#156HUMANIZED ANTI-MUC1* ANTIBODIES AND DIRECT USE OF CLEAVAGE ENZYME
#157Methods of treating wounds using cathepsin K inhibitors
#158PROLIFERATION OF MUC1 EXPRESSING CELLS
#159Stabilized liquid and lyophilized ADAMTS13 formulations
#160ENDOTOXIN-REDUCED THERMOLYSIN
#161Process for the production and purification of the collagenase enzyme from
#162Diagnostic agent and medicine comprising ADAMTS13 as main ingredient
#163NOVEL ANTIBACTERIAL COMPOUNDS AND METHODS OF MAKING AND USING SAME
#164Biodegradable biomimetics of growth plate cartilage for the treatment of physeal injuries
#165Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress
#166Thermostable Composition Having Antiviral and Antibacterial Activity and the Use Thereof
#167Solubilizate with curcumin and boswellia and xanthohumol
#168Nucleic acid molecules encoding clostridium histolyticum collagenase I and methods of producing the same
#169Collagen-mimetic peptide mediated delivery of nucleic acid carriers for efficient delivery from collagen
#170Pharmaceutical composition containing botulinum neurotoxin
#171Engineered anthrax protective antigen proteins for cancer therapy
#172RNAs for wound healing
#173METHOD FOR MONOMERIZING MATRIX METALLOPROTEINASE 7 (MMP-7) AGGREGATE
#174ENZYMATIC WOUND DEBRIDING COMPOSITIONS WITH ENHANCED ENZYMATIC ACTIVITY
#175DELIVERY OF AUTOLOGOUS CELLS COMPRISING MATRIX METALLOPROTEINASE FOR TREATMENT OF SCLERODERMA
#176Solubilizate with curcumin and optionally at least one other active substance
#177Subcutaneous administration of ADAMTS13
#178Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#179Deimmunized lysostaphin and methods of use
#180Composition, containing RGD motif-containing peptide or fragment thereof, for treating burns and glaucoma, alleviating skin wrinkles, and promoting hair growth
#181Methods and compositions for inhibiting ADAM 9 biological activities
#182Chimeric polypeptides and their use in bacterial decolonization
#183Contact lens use in the treatment of an ophthalmologic condition
#184Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
#185AAV-BASED GENE THERAPY FOR GLAUCOMA
#186METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES
#187CONJUGATED PROTEASE TARGETING MOIETIES
#188Variants of TACE pro-domain as TNF-A inhibitor and their medical use
#189RNA for treatment or prophylaxis of a liver disease
#190Treatment and Prophylaxis for Neurological Conditions and Diseases
#191Fusion proteins of collagen-binding domain and parathyroid hormone
#192Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
#193Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)
#194Peptide directed protein knockdown
#195Vasoconstrictive and antibacterial combination treatment for rosacea
#196METHOD OF PREVENTING OR REDUCING BIOFILM FORMATION
#197Methods and compositions for reducing cardiac damage and other conditions
#198Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces
#199Stabilized liquid and lyophilized ADAMTS13 formulations
#200Implantable matrix having optimum ligand concentrations
#201HEAT-EXPOSED PLATELET LYSATE COMPOSITIONS, AND METHODS FOR PREPARING AND USING SAME
#202METHODS TO TREAT HEART FAILURE
#203Flexible tissue matrix and methods for joint repair
#204CELL MEMBRANE TRANSLOCATION OF REGULATED SNARE INHIBITORS, COMPOSITIONS THEREFOR, AND METHODS FOR TREATMENT OF DISEASE
#205ADAMTS13-containing compositions having thrombolytic activity
#206Delivery system comprising a proteolytic enzyme or effector thereof for use in a method for oral treatment and uses thereof
#207Methods of treating cancer using cell based therapies
#208Hydrogel for engineered immune response to D-chirality peptides
#209Fusion proteins of collagen-binding domain and parathyroid hormone
#210A device for ultrasonic-accelerated hematoma lysis or thrombolysis of intracerebral or intraventricular hemorrhages or hematomas
#211COMPOSITIONS, SYSTEMS, AND METHODS FOR SCAR TISSUE MODIFICATION
#212Oral microbiota promotion for immune system associated inflammations
#213DERMATOLOGICAL COMPOSITION AUGMENTING PARACRINE SIGNALLING
#214ENZYME-ACTIVATED COLLAGEN AND TISSUE MATRICES
#215DEVICES AND METHODS FOR REDUCING THE APPEARANCE OF CELLULITE
#216Enzymatic wound debriding compositions with enhanced enzymatic activity
#217COMPOSITION AND METHOD OF PREPARATION OF PROTEASE MICROPARTICULATE SLOW RELEASE PREPARATION
#218Methods for Treating Cellulite
#219Human monoclonal autoantibodies to ADAMTS13 and uses thereof
#220Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
#221CELL TRANSPLANTATION DEVICE
#222Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes
#223Cell therapy for the treatment of neurodegeneration
#224ENZYME COMPOSITION FOR MANAGEMENT OF METABOLIC HEALTH
#225Collagenase-derived peptides promote tissue regeneration and wound healing
#226Chimeric polypeptides and their use in bacterial decolonization
#227MATERIALS AND METHODS FOR TREATING EMBOLISM
#228COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS
#229Cationic neurotoxins
#230Functionalized tissue matrices
#231Method of assessing and treating cellulite
#232Medicine for treatment and/or prevention of ischemic diseases, method for improving angiogenesis-promoting activity of cells, or method for producing medicine
#233Method of treating stroke by administering a compound that inhibits VEGF-B signaling in combination with a thrombolytic agent
#234Engineered anthrax protective antigen proteins for cancer therapy
#235Stabilized liquid and lyophilized ADAMTS13 formulations
#236Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#237Animal product-free culture medium for bacteria of the genus and a process for producing supernatant comprising one or more collagenolytic and gelatinolytic proteases
#238Treatment for gastroesophageal reflux disease caused by a neurological disorder
#239METHODS RELATING TO THE TREATMENT OF COLITIS AND INFLAMMATORY BOWEL DISEASE
#240MODULATION OF MUSCLE AND ADIPOCYTE DISTRIBUTION AND FATE
#241Directed stem cell recruitment
#242Compositions for remodeling extracellular matrix and methods of use thereof
#243LIVER CIRRHOSIS TREATMENT
#244Therapeutic methods, products and compositions inhibiting ZNF555
#245ENZYME COMPOSITION FOR THERAPEUTIC MANAGEMENT OF MUSCLE SORENESS
#246COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION
#247Use of alginate oligomers in combating biofilms
#248COMPOSITIONS AND METHODS FOR REGULATING SAS1R
#249Clostridium histolyticum enzymes and methods for the use thereof
#250Multimodal antimicrobial therapy
#251ADAM12 inhibitors and their use against inflammation-induced fibrosis
#252BMP peptides and methods of use
#253Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof
#254Composition, containing RGD motif-containing peptide or fragment thereof, for treating burns and glaucoma, alleviating skin wrinkles, and promoting hair growth
#255Collagenous tissue repair device
#256Use of protease mixture in promoting wound healing
#257METHOD OF ISOLATING CELLS FROM A TISSUE IN A MAMMAL
#258PROTEASE COMPOSITIONS FOR USE IN MODIFYING SEMEN
#259Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
#260Composition and method of preparation of protease microparticulate slow release preparation
#261Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#262Cell therapy for the treatment of neurodegeneration
#263Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#264Pharmaceutical formulations of xanthine or xanthine derivatives, and their use
#265Process for the production and purification of the collagenase enzyme from vibrio alginolyticus
#266Implantable matrix having optimum ligand concentrations
#267Variants of TACE pro-domain as TNF-A inhibitor and their medical use
#268ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
#269Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
#270Methods and systems for toxin delivery to the nasal cavity
#271Treatment of ophthalmic conditions
#272COATED PARTICLES FOR DRUG DELIVERY
#273Human amniotic fluid preparation having long-term stability
#274Treatment and prophylaxis for neurological conditions and diseases
#275Subcutaneous administration of ADAMTS13
#276Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers
#277Delivery system comprising a proteolytic enzyme or effector thereof for use in a method for oral treatment and uses thereof
#278Fungal-specific metalloproteases and uses thereof
#279Hatching fluid enzymes and uses thereof
#280Gene therapy for neurometabolic disorders
#281METHODS OF INCREASING MUSCLE MASS USING NON-TOXIC TETANUS TOXIN C FRAGMENT (TTC)
#282Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Disease
#283Deimmunized lysostaphin and methods of use
#284Stabilized liquid and lyophilized ADAMTS13 formulations
#285PHARMACEUTICAL COMPOSITION AGAINST CHRONIC BACTERIAL INFECTIONS
#286Fusion proteins of collagen-binding domain and parathyroid hormone
#287Reduction of Lipoma Tissue
#288COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#289Method for monomerizing matrix metalloproteinase 7 (MMP-7) aggregate
#290Enzymatic wound debriding compositions with enhanced enzymatic activity
#291Enzyme-activated collagen and tissue matrices
#292Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV
#293Cell Membrane Translocation of Regulated Snare Inhibitors, Compositions Therefor, and Methods for Treatment of Disease
#294Reduced-pressure treatment systems and methods employing debridement mechanisms
#295Stabilized liquid and lyophilized ADAMTS13 formulations
#296Cationic neurotoxins
#297Treatment of ophthalmic conditions
#298Method for Treating Adhesive Capsulitis
#299Thermosensitive hydrogel collagenase formulations
#300Gelatinase inhibitors and prodrugs